Assessment of Serum Concentration of Interleukin-17 and Osteoprotegerin in Response to Surgical Trauma Induced by Management of Mandibular Fractures Via Intraoral Versus Extraoral Approaches: Prospective Cohort Study
1 other identifier
observational
2
0 countries
N/A
Brief Summary
Assessment of Serum Concentration of Interleukin-17 and Osteoprotegerin in Response to Surgical Trauma Induced by Management of Mandibular Fractures via Intraoral Versus Extraoral Approaches: Prospective Cohort Study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedStudy Start
First participant enrolled
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedApril 5, 2024
March 1, 2024
Same day
March 31, 2024
March 31, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
IL-17
Interleukin-17
6- weeks
OPG
Osteoprotegerin
6- weeks
Secondary Outcomes (2)
Blood Loss
in operation room
Operative time
Operative time in minutes
Study Arms (2)
Management of Mandibular Fractures via Intraoral approach.
Management of Mandibular Fractures via Intraoral approach.
Management of Mandibular Fractures via Extraoral approach.
Management of Mandibular Fractures via Extraoral approach.
Interventions
Open Reduction \& Internal Fixation of Mandibular fracture either through intraoral or extraoral approaches.
Eligibility Criteria
Patients with single mandibular fracture.
You may qualify if:
- Single mandibular fracture.
- ORIF is done by two plates fixation with titanium plates and screws.
- Age (18-50 years).
- Recent fracture (less than 2 weeks).
You may not qualify if:
- Pathological fractures.
- Medical compromised patient.
- Presence of concomitant injuries.
- Patients receive radiotherapy.
- Patients receive blood transfusion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aya Ayman Ahmedlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- lecturer assistant
Study Record Dates
First Submitted
March 31, 2024
First Posted
April 5, 2024
Study Start
April 15, 2024
Primary Completion
April 15, 2024
Study Completion
December 15, 2025
Last Updated
April 5, 2024
Record last verified: 2024-03